Reuters — Aurora Cannabis on Monday missed Wall Street expectations for fourth-quarter revenue as pandemic-related restrictions weighed down consumer demand, leading Canadian provinces to cut orders. U.S.-listed shares of the company, which also posted a bigger-than-expected quarterly loss, were down two per cent in extended trading. After more than three years into Canada’s legalization of […] Read more
